RGBP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 15:58):

Stats
Today's Volume	2 632.00
Average Volume	14 835.00
Market Cap	2.63M
EPS	$0 ( 2024-04-15 )
Next earnings date	( $0 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.69
ATR14	$0.0170 (2.43%)

Regen BioPharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regen BioPharma, Inc. Financials

Annual	2023
Revenue:	$236 560
Gross Profit:	$176 560 (74.64 %)
EPS:	$0.290

Q4	2023
Revenue:	$59 366.00
Gross Profit:	$44 366.00 (74.73 %)
EPS:	$-0.0799

Q3	2023
Revenue:	$58 717.00
Gross Profit:	$43 717.00 (74.45 %)
EPS:	$18.02

Q2	2023
Revenue:	$59 065.00
Gross Profit:	$44 065.00 (74.60 %)
EPS:	$-0.0115

Financial Reports:

No articles found.

Regen BioPharma, Inc.

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.